| For: | He WL, Yan S, Lu JJ, Chen L, Wu JZ. Current clinical research status and future treatment directions for liver cirrhosis combined with portal vein thrombosis. World J Hepatol 2025; 17(10): 109745 [PMID: 41179734 DOI: 10.4254/wjh.v17.i10.109745] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5182/full/v17/i10/109745.htm |
| Number | Citing Articles |
| 1 |
Zhuxiang Xiong, Rutao Xu, Chunqiu Shi, Jichun Zhao, Tinghui Zheng. Validation of the “protective flow attenuation” hypothesis: Numerical and clinical insights into helical flow and thrombotic risk in cirrhosis. Computer Methods and Programs in Biomedicine 2026; 285 doi: 10.1016/j.cmpb.2026.109513
|
| 2 |
Lavinia Alice Bălăceanu, Claudia Georgeta Iacobescu, Teodora Burloiu, Marian-Vlad Lăpădat, Ion Dina, Ion Daniel Baboi. Rare Causes of Portal Vein Thrombosis and Occlusion: A Narrative Review. Diagnostics 2026; 16(5) doi: 10.3390/diagnostics16050800
|
| 3 |
Sarah Taylor, Julie Wang, Hui Yin Lim, Glen Saward, Siddharth Sood. Balancing Thrombosis and Bleeding: Antithrombotic Therapy in Cirrhosis-Related Thrombocytopenia. Journal of Clinical Medicine 2026; 15(5) doi: 10.3390/jcm15052036
|
| 4 |
Wei Zhang, Yunhong Lei, Luhuan Yang, Saquib Waheed, Zhouzhou Fan, Su Zhou, Rong Zhang, Hui Zhang. Risk prediction models for the risk of portal vein thrombosis in patients with liver cirrhosis: a systematic review and meta-analysis. Frontiers in Medicine 2026; 13 doi: 10.3389/fmed.2026.1941691
|